These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38904912)

  • 1. Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice.
    Kulesza A; Couty C; Lemarre P; Thalhauser CJ; Cao Y
    J Pharmacokinet Pharmacodyn; 2024 Jun; ():. PubMed ID: 38904912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASAS-NANP symposium: mathematical modeling in animal nutrition: agent-based modeling for livestock systems: the mechanics of development and application.
    Kaniyamattam K; Tedeschi LO
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37997925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-specific, mechanistic models of tumor growth incorporating artificial intelligence and big data.
    Lorenzo G; Ahmed SR; Ii DAH; Vaughn B; Kalpathy-Cramer J; Solorio L; Yankeelov TE; Gomez H
    ArXiv; 2023 Aug; ():. PubMed ID: 37693182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical formalisms based on approximated kinetic representations for modeling genetic and metabolic pathways.
    Alves R; Vilaprinyo E; Hernádez-Bermejo B; Sorribas A
    Biotechnol Genet Eng Rev; 2008; 25():1-40. PubMed ID: 21412348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.
    Yankeelov TE; An G; Saut O; Luebeck EG; Popel AS; Ribba B; Vicini P; Zhou X; Weis JA; Ye K; Genin GM
    Ann Biomed Eng; 2016 Sep; 44(9):2626-41. PubMed ID: 27384942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling in autoimmune diseases: from theory to clinical application.
    Ugolkov Y; Nikitich A; Leon C; Helmlinger G; Peskov K; Sokolov V; Volkova A
    Front Immunol; 2024; 15():1371620. PubMed ID: 38550585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of cardio-oncology: Modeling the systemic effects of cancer therapeutics on the cardiovascular system.
    Casson CL; John SA; Ferrall-Fairbanks MC
    Semin Cancer Biol; 2023 Dec; 97():30-41. PubMed ID: 37979714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology.
    Peskov K; Azarov I; Chu L; Voronova V; Kosinsky Y; Helmlinger G
    Front Immunol; 2019; 10():924. PubMed ID: 31134058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
    Chelliah V; Lazarou G; Bhatnagar S; Gibbs JP; Nijsen M; Ray A; Stoll B; Thompson RA; Gulati A; Soukharev S; Yamada A; Weddell J; Sayama H; Oishi M; Wittemer-Rump S; Patel C; Niederalt C; Burghaus R; Scheerans C; Lippert J; Kabilan S; Kareva I; Belousova N; Rolfe A; Zutshi A; Chenel M; Venezia F; Fouliard S; Oberwittler H; Scholer-Dahirel A; Lelievre H; Bottino D; Collins SC; Nguyen HQ; Wang H; Yoneyama T; Zhu AZX; van der Graaf PH; Kierzek AM
    Clin Pharmacol Ther; 2021 Mar; 109(3):605-618. PubMed ID: 32686076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.
    Sové RJ; Jafarnejad M; Zhao C; Wang H; Ma H; Popel AS
    CPT Pharmacometrics Syst Pharmacol; 2020 Sep; 9(9):484-497. PubMed ID: 32618119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems immunology: a survey of modeling formalisms, applications and simulation tools.
    Narang V; Decraene J; Wong SY; Aiswarya BS; Wasem AR; Leong SR; Gouaillard A
    Immunol Res; 2012 Sep; 53(1-3):251-65. PubMed ID: 22528121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.
    Riviere JE; Gabrielsson J; Fink M; Mochel J
    J Vet Pharmacol Ther; 2016 Jun; 39(3):213-23. PubMed ID: 26592724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical models for translational and clinical oncology.
    Gallasch R; Efremova M; Charoentong P; Hackl H; Trajanoski Z
    J Clin Bioinforma; 2013 Nov; 3(1):23. PubMed ID: 24195863
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.